ACELRX PHARMACEUTICALS INC - FORM S-1/A - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - January 20, 2011

Attached files

file filename
S-1/A - AMENDMENT NO. 3 TO FORM S-1 - ACELRX PHARMACEUTICALS INCds1a.htm
EX-5.1 - OPINION OF COOLEY LLP - ACELRX PHARMACEUTICALS INCdex51.htm
EX-3.2 - FORM OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION - ACELRX PHARMACEUTICALS INCdex32.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated June 30, 2010, except for the last paragraph of Note 1, as to which the date is February     , 2011, in the Registration Statement (Amendment No. 3 to Form S-1) and related Prospectus of AcelRx Pharmaceuticals, Inc. for the registration of shares of its common stock.

Ernst & Young LLP

San Francisco, California

 

 

The foregoing consent is in the form that will be signed upon the completion of the reverse stock split described in the last paragraph of Note 1 to the financial statements.

/s/ Ernst & Young LLP

San Francisco, California

January 20, 2011

ACELRX PHARMACEUTICALS INC Reports